Friday, April 23, 2010

Global market for antifungal drugs & technologies worth $11.8 billion by 2014

The global human antifungal therapeutics market was worth around $10.2 billion in 2008 and it decreased in 2009 to be around $9.9 billion. However, the market is anticipated to reach $11.8 billion in 2014 at a 5 year CAGR of 3.8%.

Learn about the major markets for antifungal applications in human healthcare, with an extensive review of therapies in human development phases I-III...

Use this report to:
  • Receive in-depth analysis of the current human antifungal market and explore the direction the market is going, with a strong emphasis on early research due to the critical need for new and more effective medicines
  • Understand the human applications both marketed and in the development of antifungal technology; extensive analysis of each market segment, current market status, and forecasts for growth over the next 5 years
  • See 5-year financial and sales projections and trends from 2009 through 2014; based on other factors such as FDA restrictions, government legislation, fungal resistance, and changes in the consumerism as a greater demand for OTC medications and/or natural and alternative remedies has arose
  • Determine the current status of the global human antifungal market and assess its growth potential over the 5 year period from 2009 through 2014.
To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

No comments:

Post a Comment

Bookmark and Share